Literature DB >> 7752058

Presynaptic inhibition of gamma-aminobutyric acidB-mediated synaptic current by adenosine recorded in vitro in midbrain dopamine neurons.

Y N Wu1, N B Mercuri, S W Johnson.   

Abstract

Adenosine receptor antagonists such as caffeine cause dopamine-dependent behavioral arousal and hyperlocomotion in rodents. In the present study, we used the whole-cell recording technique in the rat brain slice to investigate effects of adenosine on dopamine neurons and their synaptic inputs in the substantia nigra zona compacta and ventral tegmental area. Adenosine was most potent for inhibiting the amplitude of the inhibitory postsynaptic current (IPSC) mediated by gamma-aminobutyric acid (GABA)B receptors (EC50 = 47 +/- 3 microM) compared with inhibition of the GABAA-mediated IPSC (117 +/- 51 microM) and the excitatory amino acid-mediated excitatory postsynaptic current (119 +/- 36 microM). Adenosine failed to inhibit current evoked by exogenous GABA or baclofen, suggesting that adenosine acted presynaptically to reduce GABA release from nerve terminals. Adenosine inhibited the GABAB-mediated IPSC by acting at the adenosine A1 receptor, because its effect was blocked by the selective adenosine A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (100 nM), as well as by the methylxanthines caffeine (1 mM) and theophylline (300 microM). The rank-order of potency of adenosine agonists [N6-cyclohexyladenosine > R-(-)-N6-(2-phenylisopropyl)-adenosine = N6- cyclohexyladenosine > 5'-N-ethylcarboxamidoadenosine > 2-chloroadenosine] also was consistent with activation of the adenosine A1 receptor, whereas the selective adenosine A2A agonist CGS 21680 [2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamido adenosine] had no effect on the GABAB IPSC. None of the adenosine agonists or antagonists affected holding current or membrane conductance.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752058

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  Presynaptic inhibition preferentially reduces in NMDA receptor-mediated component of transmission in rat midbrain dopamine neurons.

Authors:  Y N Wu; K Z Shen; S W Johnson
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Increased probability of GABA release during withdrawal from morphine.

Authors:  A Bonci; J T Williams
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

3.  Alkylxanthine adenosine antagonists and epileptiform activity in rat hippocampal slices in vitro.

Authors:  A J Chesi; T W Stone
Journal:  Exp Brain Res       Date:  1997-02       Impact factor: 1.972

4.  Presynaptic GABAB and adenosine A1 receptors regulate synaptic transmission to rat substantia nigra reticulata neurones.

Authors:  K Z Shen; S W Johnson
Journal:  J Physiol       Date:  1997-11-15       Impact factor: 5.182

5.  Presynaptic dopamine D2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones.

Authors:  E Koga; T Momiyama
Journal:  J Physiol       Date:  2000-02-15       Impact factor: 5.182

6.  Operant, oral alcoholic beer self-administration by C57BL/6J mice: effect of BHF177, a positive allosteric modulator of GABA(B) receptors.

Authors:  Alessandro Orrù; Daniele Fujani; Chiara Cassina; Mirko Conti; Angelo Di Clemente; Luigi Cervo
Journal:  Psychopharmacology (Berl)       Date:  2012-03-13       Impact factor: 4.530

7.  Dopamine selectively reduces GABA(B) transmission onto dopaminergic neurones by an unconventional presynaptic action.

Authors:  Mauro Federici; Silvia Natoli; Giorgio Bernardi; Nicola B Mercuri
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

8.  L-Type calcium channels mediate a slow excitatory synaptic transmission in rat midbrain dopaminergic neurons.

Authors:  A Bonci; P Grillner; N B Mercuri; G Bernardi
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

9.  GABA release modified by adenosine receptors in mouse hippocampal slices under normal and ischemic conditions.

Authors:  Pirjo Saransaari; Simo S Oja
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

10.  The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release.

Authors:  Sondra T Bland; Mark R Hutchinson; Steven F Maier; Linda R Watkins; Kirk W Johnson
Journal:  Brain Behav Immun       Date:  2009-02-03       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.